Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Adamas Pharmaceuticals Inc (NASDAQ: ADMS) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Adamas Pharmaceuticals Inc (NASDAQ: ADMS) concerning whether a series of statements by Adamas Pharmaceuticals Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

In January 2018, the Company completed a secondary public offering ("SPO"), issuing approximately 3 million shares of common stock priced at $41.50 per share.

In October 2018, a released study by Merrill Lynch shed serious doubt on the ability of Gocovri, the Company’s treatment for dyskinesia in Parkinson's disease patients treated with levodopa therapy, to achieve a sizeable market share and emphasized that Adamas had failed to include critical information.

In March 2019, the Company backtracked on prior issued growth estimates and no longer made predictions regarding Gocovri's ability to achieve a sizeable market share.

Following this news, NASDAQ: ADMS fell sharply since the SPO.

Based in Emeryville, California, and founded in 2000 Adamas Pharmaceuticals Inc focuses on the discovery, development, and commercialization of medicines for patients suffering from chronic neurologic disorders.

If you purchased shares of Adamas Pharmaceuticals Inc (NASDAQ: ADMS) pursuant to the Company's January 24, 2018 secondary public offering, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185